Putnam Valley, NY. (April 25, 2016) - Liver failure often occurs after an extensive hepatectomy, which is the surgical resection of the liver. While liver cell transplantation is a useful therapy for acute liver failure after massive hepatectomy, when cells are transplanted through liver portal veins raises the risk of embolization, such as the formation and movement of a blood clot, often with fatal consequences.
Experimenting with rat models, researchers investigated safer ways to transplant liver cells post-extensive hepatectomy and found that transplanting the cells into an extra-hepatic site, such as the intra-mesentery, a fold of membranous tissue on the posterior wall of the abdominal cavity that attaches to the intestinal tract, can help to protect against post-operative liver failure and aid in survival of the remaining liver.
Their study will be published in a future issue of Cell Transplantation and is currently freely available on-line as an unedited, early epub at: http://www.
"The overall mortality due to acute liver failure significantly improved in the transplantation group," said study co-author Dr. Kentaro Yasuchika of the Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
To investigate whether hepatocytes or non-parenchymal cells (NPCs) that secrete a variety of growth factors and participate in liver growth played a more significant role in protecting remnant livers and promoting hepatic regeneration, liver cells harvested from the donor liver tissue were divided into hepatocytes and NPCs, with each transplanted separately in one arm of the study. The researchers found that post-operative liver damage was not prevented by NPCs alone and speculated that the protective effect was mainly because the hepatocytes transplanted into the mesentery contributed to hepatocyte survival and protected against acute liver failure.
"Although transplanted liver cells hardly worked as functional liver cells in the very early period after transplantation, they protected the remaining liver tissue and cells from severe damage after massive hepatectomy, which could have a major effect on survival of the remnant liver," concluded the researchers. "Further experiments should be planned for diseased recipients with chronic liver failure, metabolic live failure, and liver cirrhosis to utilize this technique in a clinical setting."
"Liver failure is a life-threatening condition that has many causes, thus effecting varied, diverse portions of the population," said Dr. Stephen Strom, professor of Cell Transplantation and Regenerative Medicine, Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden. "The condition may necessitate surgery, which can lead to augmentation of these complications. The need for additional therapeutic options is keenly felt and future studies should address the safety of this method for translation to patients."
Contact: Dr. Kentaro Yasuchika, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto, Japan,606-8507
Citation: Kito S, Yasuchika K, Ishii T, Katayama H, Yoshitoshi EY, Ogiso S, Kawai T, Yasuda K, Fukumitsu K, Mizumoto M, Uemoto S. The protective effect of transplanted liver cells into the mesentery on the rescue of acture liver failure after massive hepatectomy. Cell Transplant. Appeared or available on-line: February 15, 2016.
The Coeditors-in-Chief for CELL TRANSPLANTATION are at the Department of Neurosurgery and Brain Repair, Morsani College of Medicine, University of South Florida, Tampa, FL, USA and the Center for Neuropsychiatry, China Medical University Hospital, TaiChung, Taiwan. Contact: Paul R. Sanberg at email@example.com, Shinn-Zong Lin at firstname.lastname@example.org, or Associate Editor Samantha Portis at email@example.com
News release by Florida Science Communications http://www.